|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1996-12-30
|
|
pubmed:abstractText |
Topical apraclonidine hydrochloride 1% is effective for controlling the intraocular pressure (IOP) rise following argon laser trabeculoplasty (ALT). The 0.5% formulation has recently become available commercially. The objective of this study was to compare the efficacy of these two concentrations for controlling IOP after ALT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1082-3069
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
657-60
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8858630-Administration, Topical,
pubmed-meshheading:8858630-Adrenergic alpha-Agonists,
pubmed-meshheading:8858630-Clonidine,
pubmed-meshheading:8858630-Follow-Up Studies,
pubmed-meshheading:8858630-Glaucoma,
pubmed-meshheading:8858630-Humans,
pubmed-meshheading:8858630-Intraocular Pressure,
pubmed-meshheading:8858630-Laser Therapy,
pubmed-meshheading:8858630-Ocular Hypertension,
pubmed-meshheading:8858630-Ophthalmic Solutions,
pubmed-meshheading:8858630-Postoperative Complications,
pubmed-meshheading:8858630-Prospective Studies,
pubmed-meshheading:8858630-Trabeculectomy
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
|
|
pubmed:affiliation |
Duke University Eye Center, Durham, NC 27710, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
